Company news

Inotiv, Inc. news in 2021

Inotiv, Inc.'s news releases, calls and decks from 2021, newest first.

View company

Inotiv, Inc. Announces Fourth Quarter and Full Year Fiscal 2021 Financial Results

December 15, 2021

Inotiv, Inc. Reschedules Fourth Quarter Fiscal 2021 Financial Results and Conference Call for Thursday, December 16, 2021

December 12, 2021

Inotiv, Inc. Announces the Launch of New Genetically Engineered Rodent Models for SARS-CoV-2 (COVID-19) Research

December 12, 2021

Inotiv, Inc. Announces Select Preliminary Unaudited Financial Results for the Fourth Quarter and Full Year Fiscal 2021

December 6, 2021

Inotiv, Inc. to Report Fourth Quarter Fiscal 2021 Financial Results and Host Conference Call on Tuesday, December 7, 2021

November 28, 2021

Inotiv, Inc. Announces Opening of Newly-Constructed Laboratories at St. Louis Facility

November 9, 2021

Inotiv, Inc. Completes Purchase of Envigo

November 4, 2021

Inotiv, Inc. Shareholders Approve Acquisition of Envigo

November 3, 2021

Inotiv, Inc. Announces Expansion of In Vivo Pharmacology Offering with Acquisition of Plato BioPharma, Inc.

October 3, 2021

Inotiv, Inc. Announces Closing of $125 Million Convertible Senior Notes Offering and Full Exercise of Option to Purchase Additional $15 Million of Notes

September 26, 2021

Inotiv, Inc. Prices Upsized $125 Million Convertible Senior Notes Offering

September 21, 2021

Inotiv, Inc. Announces Proposed Convertible Senior Notes Offering

September 20, 2021

Inotiv, Inc. Announces Third Quarter Fiscal 2021 Financial Results

August 10, 2021

Inotiv, Inc. Announces Acquisition of Gateway Pharmacology Laboratories

August 1, 2021

Inotiv, Inc. to Report Third Quarter Fiscal 2021 Financial Results and Host Conference Call on Wednesday, August 11, 2021

July 21, 2021

Inotiv Acquires Laboratory Instrumentation for Discovery and Development of Novel Therapies

July 14, 2021

Inotiv Acquires Genetic Toxicology Assets from MilliporeSigma’s BioReliance® portfolio

July 11, 2021

Inotiv, Inc. Broadens Pathology Services to Include Medical Device Pathology and Hires Nicolette Jackson to Lead Effort

June 27, 2021

Inotiv Announces Purchase of St. Louis Facility and Plans to Expand Capacity

May 26, 2021

Kenneth Swart, Ph.D., Joins Inotiv as Vice President, Bioanalytical Sciences to Drive Growth of Expanding Laboratory Solutions Offerings

May 10, 2021

Inotiv, Inc. Announces Second Quarter Fiscal 2021 Financial Results

May 4, 2021

Inotiv, Inc. Announces Debt Financing and Completion of Acquisitions of HistoTox Labs, Inc. and Bolder BioPATH, Inc.

April 29, 2021

Inotiv, Inc. Announces Closing of Public Offering and Full Exercise of Underwriter’s Option to Purchase Additional Shares

April 22, 2021

Inotiv, Inc. Announces Pricing of Public Offering of 2,647,059 Common Shares

April 20, 2021

Inotiv, Inc. Announces Select Preliminary Unaudited Financial Results for Second Quarter and Year to Date Fiscal 2021

April 19, 2021

Inotiv, Inc. Announces Proposed Public Offering of Common Shares

April 19, 2021

Inotiv, Inc. Announces Plan to Expand the Company’s Internal Operations

April 18, 2021

Inotiv, Inc. Announces Expansion of Pharmacology and Pathology Offerings with Agreement to Purchase Bolder BioPATH, Inc.

April 15, 2021

Inotiv, Inc. Enhances Histopathology Offering with Announcement of Agreement to Purchase HistoTox Labs, Inc.

April 12, 2021

Inotiv, Inc. Announces Partnership with PhoenixBio Co., Ltd. to Expand Discovery Pharmacology Offering

April 5, 2021

Bioanalytical Systems, Inc., doing business as Inotiv, Announces Plan to Expand Service Offerings to Include Cardiovascular Safety Pharmacology

March 16, 2021

Inotiv Broadens Pathology Service Offerings

January 18, 2021

Daniel Smeak, DVM, ACVS, Joins Inotiv as Vice President, Surgical Models

January 10, 2021

Calls in 2021

Decks in 2021